Vertex Pharmaceuticals Incorporated (VRTX)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS92532F1003
542.62 USD
-0.81% today Updated 13 Nov 2026 14:11
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Vertex Pharmaceuticals Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:11. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
11 Feb 2027
in 90 days · 16:00 · estimate 4.10
Last results
4.76 vs 4.78 estimated
02 Nov 2026 · In line -0.5%
Beat the estimate
6 of 12
4 missed · 2 in line
Average surprise
+1.9%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 16:00 | 4.10 | — | — | Upcoming |
| 02 Nov 2026 16:00 | 4.78 | 4.76 | -0.5% | In line |
| 03 Aug 2026 16:00 | 4.75 | 4.73 | -0.3% | In line |
| 04 May 2026 16:00 | 4.31 | 4.47 | +3.8% | Beat |
| 12 Feb 2026 16:00 | 5.15 | 5.03 | -2.3% | Miss |
| 03 Nov 2025 16:00 | 4.58 | 4.80 | +4.9% | Beat |
| 04 Aug 2025 16:00 | 4.25 | 4.52 | +6.3% | Beat |
| 05 May 2025 16:00 | 4.29 | 4.06 | -5.4% | Miss |
| 10 Feb 2025 16:00 | 4.02 | 3.98 | -1.0% | Miss |
| 04 Nov 2024 16:00 | 4.13 | 4.38 | +6.0% | Beat |
| 01 Aug 2024 16:00 | -11.75 | -12.83 | -9.2% | Miss |
| 06 May 2024 16:00 | 4.06 | 4.76 | +17.3% | Beat |
| 05 Feb 2024 16:00 | 4.09 | 4.20 | +2.8% | Beat |
| 06 Nov 2023 16:00 | 3.97 | 4.08 | +2.7% | Beat |
| 01 Aug 2023 16:00 | 3.88 | 3.89 | +0.2% | In line |
| 01 May 2023 16:00 | 3.00 | 3.05 | +1.6% | Beat |
| 07 Feb 2023 16:00 | 3.51 | 3.76 | +7.1% | Beat |
| 27 Oct 2022 16:00 | 3.64 | 4.01 | +10.1% | Beat |
| 04 Aug 2022 16:00 | 3.50 | 3.60 | +2.8% | Beat |
| 05 May 2022 16:00 | 3.54 | 3.52 | -0.4% | In line |
| 26 Jan 2022 16:00 | 3.29 | 3.37 | +2.5% | Beat |
| 02 Nov 2021 16:00 | 3.07 | 3.56 | +15.9% | Beat |
| 29 Jul 2021 16:00 | 2.38 | 3.11 | +30.7% | Beat |
| 29 Apr 2021 16:00 | 2.69 | 2.98 | +10.8% | Beat |
| 01 Feb 2021 16:00 | 2.55 | 2.51 | -1.6% | Miss |
| 29 Oct 2020 16:00 | 2.33 | 2.64 | +13.3% | Beat |
| 30 Jul 2020 16:00 | 2.08 | 2.61 | +25.3% | Beat |
| 29 Apr 2020 17:00 | 1.85 | 2.56 | +38.6% | Beat |
| 30 Jan 2020 16:00 | 1.22 | 1.70 | +39.9% | Beat |
| 30 Oct 2019 16:00 | 1.16 | 1.23 | +5.7% | Beat |
| 31 Jul 2019 16:00 | 1.07 | 1.26 | +17.3% | Beat |
| 30 Apr 2019 16:00 | 1.01 | 1.14 | +13.1% | Beat |
| 05 Feb 2019 16:00 | 1.06 | 1.30 | +22.3% | Beat |
| 24 Oct 2018 16:00 | 1.01 | 1.09 | +8.0% | Beat |
| 25 Jul 2018 16:00 | 0.75 | 0.94 | +25.9% | Beat |
| 26 Apr 2018 16:00 | 0.63 | 0.76 | +20.9% | Beat |
| 31 Jan 2018 16:00 | 0.54 | 0.61 | +13.6% | Beat |
| 25 Oct 2017 16:00 | 0.37 | 0.53 | +44.0% | Beat |
| 26 Jul 2017 16:00 | 0.36 | 0.39 | +8.1% | Beat |
| 27 Apr 2017 16:00 | 1.05 | 1.33 | +26.9% | Beat |
| 25 Jan 2017 16:00 | 0.29 | 0.35 | +21.4% | Beat |
| 25 Oct 2016 16:00 | 0.19 | 0.16 | -14.8% | Miss |
| 27 Jul 2016 16:00 | 0.20 | 0.24 | +17.2% | Beat |
| 27 Apr 2016 16:00 | 0.28 | 0.09 | -67.7% | Miss |
| 27 Jan 2016 16:00 | 0.16 | 0.17 | +8.5% | Beat |
| 28 Oct 2015 16:00 | -0.27 | -0.13 | +52.3% | Beat |
| 29 Jul 2015 16:00 | -0.58 | -0.54 | +7.6% | Beat |
| 29 Apr 2015 16:00 | -0.57 | -0.62 | -9.2% | Miss |
| 28 Jan 2015 16:00 | -0.46 | -0.55 | -19.2% | Miss |
| 28 Oct 2014 16:00 | -0.43 | -0.37 | +14.8% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 12B | +8.9% | 4B | 32.9% | 15.32 | +836.5% | 3.2B |
| 2024 | 11B | +11.7% | -535.6M | -4.9% | -2.08 | -115.0% | -978M |
| 2023 | 9.9B | +10.5% | 3.6B | 36.7% | 13.89 | +8.3% | 3.3B |
| 2022 | 8.9B | — | 3.3B | 37.2% | 12.82 | — | 3.9B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 555.99 | 555.99 | 535.46 | 542.62 | -0.82% | 4,515,500 | |
| 02 Nov 2026 – 06 Nov 2026 | 560.88 | 568.67 | 527.38 | 547.09 | -2.11% | 11,164,400 | |
| 26 Oct 2026 – 30 Oct 2026 | 526.86 | 563.80 | 509.21 | 558.88 | +6.67% | 8,061,000 | |
| 19 Oct 2026 – 23 Oct 2026 | 500.00 | 537.81 | 499.50 | 523.93 | +4.84% | 6,451,100 | |
| 12 Oct 2026 – 16 Oct 2026 | 512.44 | 517.68 | 484.08 | 499.74 | -2.03% | 7,905,200 | |
| 05 Oct 2026 – 09 Oct 2026 | 504.78 | 514.90 | 496.15 | 510.08 | +1.06% | 5,465,300 | |
| 28 Sep 2026 – 02 Oct 2026 | 524.27 | 529.89 | 499.95 | 504.73 | -4.08% | 4,792,300 | |
| 21 Sep 2026 – 25 Sep 2026 | 506.85 | 528.99 | 501.01 | 526.19 | +3.51% | 5,203,900 | |
| 14 Sep 2026 – 18 Sep 2026 | 522.17 | 525.29 | 505.01 | 508.34 | -1.38% | 5,632,400 | |
| 08 Sep 2026 – 11 Sep 2026 | 529.64 | 535.00 | 511.81 | 515.44 | -5.62% | 3,769,900 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Vertex Resource Group Ltd. Reports Third Quarter 2026 Results (opens in a new tab) 12 Nov 2026 22:35
- BioNTech vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027? (opens in a new tab) Motley Fool · 11 Nov 2026 21:00
- Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know (opens in a new tab) Zacks · 11 Nov 2026 20:21
- What Will Decide Vertex Stock Over The Next Six Months? (opens in a new tab) Trefis · 11 Nov 2026 15:38
- Missed Vertex Pharmaceuticals' Run? What Holders Had To Believe (opens in a new tab) Simply Wall St. · 08 Nov 2026 20:07
- Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027? (opens in a new tab) Motley Fool · 07 Nov 2026 14:57
- Vertex Pharmaceuticals: Costs Now Outgrow Sales, And The Price Needs A Second Vertex (opens in a new tab) SeekingAlpha · 06 Nov 2026 04:07
- Prediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 Years (opens in a new tab) Motley Fool · 05 Nov 2026 22:07
- Vertex Pharmaceuticals Incorporated 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 05 Nov 2026 02:55
- Vertex to Participate in Upcoming Investor Conferences (opens in a new tab) 04 Nov 2026 21:00
- Barclays Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $626 (opens in a new tab) Benzinga · 04 Nov 2026 15:04
- Vertex Pharmaceuticals Thrives on Higher Sales and Guidance (opens in a new tab) FX Empire · 04 Nov 2026 11:47
- Vertex Pharmaceuticals Inc (VRTX) Q3 2026 Earnings Call Highlights: Revenue Up 12% as CF, ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 11:02
- Vertex Slumps On Light Pain Drug Sales, But A Key Kidney Catalyst Lies Ahead (opens in a new tab) Investor's Business Daily · 03 Nov 2026 21:31
- Vertex Pharmaceuticals earnings analysis: questions answered and next catalysts (opens in a new tab) Investing.com · 03 Nov 2026 18:24
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 547.03 USD
- Market cap
- 137.6B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow VRTX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.